tiprankstipranks
Trending News
More News >
Deltagen Inc (DGEN)
OTHER OTC:DGEN
US Market

Deltagen (DGEN) Price & Analysis

Compare
7 Followers

DGEN Stock Chart & Stats

$0.02
<$0.01(9900.00%)
At close: 4:00 PM EST
$0.02
<$0.01(9900.00%)

DGEN FAQ

What was Deltagen Inc’s price range in the past 12 months?
Deltagen Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
    What is Deltagen Inc’s market cap?
    Deltagen Inc’s market cap is $39.00.
      When is Deltagen Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Deltagen Inc’s earnings last quarter?
      Currently, no data Available
      Is Deltagen Inc overvalued?
      According to Wall Street analysts Deltagen Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Deltagen Inc pay dividends?
        Deltagen Inc does not currently pay dividends.
        What is Deltagen Inc’s EPS estimate?
        Deltagen Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Deltagen Inc have?
        Deltagen Inc has 38,594,000 shares outstanding.
          What happened to Deltagen Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Deltagen Inc?
          Currently, no hedge funds are holding shares in DGEN
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Deltagen Inc

            Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.
            Similar Stocks
            Company
            Price & Change
            Follow
            GlucoTrack
            Femasys
            Meihua International Medical Technologies Co., Ltd.
            Innovative Eyewear, Inc.
            WORK Medical Technology Group LTD
            Popular Stocks